Protecting Americans from Unsafe Drugs Act of 2022
Official title: To amend the Federal Food, Drug, and Cosmetic Act to expand certain authorities with respect to the recall of controlled substances to apply with respect to all drugs, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Protecting Americans from Unsafe Drugs Act of 2022
This bill expands the authority of the Secretary of the Department of Health and Human Services (HHS) to order the recall of controlled substances to cover all drugs.
Furthermore, the authority to issue such an order may be delegated to the Director of the Center for Drug Evaluation and Research or the Director of the Center for Biologics Evaluation and Research (or an official senior to either director), whereas currently this authority may only be delegated to the Director of the Center for Drug Evaluation and Research or an official senior to such director. (Both centers are located in the Food and Drug Administration within HHS.)
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 6545: Protecting Americans from Unsafe Drugs Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-HR-6545/
"H.R. 6545: Protecting Americans from Unsafe Drugs Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-6545/.
H.R. 6545, 117th Cong. (2026), https://openamerica.io/bill/117-HR-6545/.
[H.R. 6545: Protecting Americans from Unsafe Drugs Act of 2022](https://openamerica.io/bill/117-HR-6545/)